These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6583985)

  • 21. Genetic research in psychiatry. Proceedings of a "Münchener Genetik-Gespräche" International Symposium. Berlin, 27-28 September 1986. A satellite symposium of the VIIth International Congress on Human Genetics.
    J Psychiatr Res; 1987; 21(4):333-647. PubMed ID: 3440949
    [No Abstract]   [Full Text] [Related]  

  • 22. [Sulpiride: a new psychotropic compound].
    Halpern B; Winnik HZ; Sircovich O
    Harefuah; 1974 Jun; 86(11):552-5. PubMed ID: 4849821
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of long-lasting sulpiride therapy on growth hormone secretion in mentally disturbed children.
    Brambilla F; Guareschi-Cazzullo A; Musetti C; Musetti L; Nobile P
    Clin Ther; 1981; 4(2):95-102. PubMed ID: 7296596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proceedings: Anti-nociceptive effects in N-substituted cyclohexylmethylbenzamides.
    Brittain RT; Kellett DN; Neat ML; Stables R
    Br J Pharmacol; 1973 Sep; 49(1):158P-159P. PubMed ID: 4207044
    [No Abstract]   [Full Text] [Related]  

  • 25. Remoxipride, a novel atypical neuroleptic, in the treatment of schizophrenia.
    den Boer JA; Verhoeven WM; Westenberg HG
    Psychopharmacol Bull; 1987; 23(1):206-10. PubMed ID: 2955447
    [No Abstract]   [Full Text] [Related]  

  • 26. Ethopharmacology: primate models of neuropsychiatric disorders. Proceedings of the symposium on primate ethopharmacology, IX congress of the International Primatological Society. Atlanta, Georgia, August 1982.
    Prog Clin Biol Res; 1983; 131():1-334. PubMed ID: 6417667
    [No Abstract]   [Full Text] [Related]  

  • 27. Foreword. The clinical aspects of deficit in dopaminergic ways.
    Gessa GL; Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():2 p following table of contents. PubMed ID: 12685915
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetics and metabolism of the benzamides.
    Bateman DN
    Adv Biochem Psychopharmacol; 1982; 35():143-62. PubMed ID: 6183928
    [No Abstract]   [Full Text] [Related]  

  • 29. Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
    Dervaux A; Cazali J
    J Clin Psychopharmacol; 2007 Oct; 27(5):514-6. PubMed ID: 17873688
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical evaluation of sulpiride].
    Nurowska K
    Psychiatr Pol; 1980; 14(1):37-42. PubMed ID: 6988858
    [No Abstract]   [Full Text] [Related]  

  • 31. [Sulpiride: the best known atypical, safe neuroleptic drug. Review of literature].
    Rzewuska M
    Psychiatr Pol; 1998; 32(5):655-66. PubMed ID: 9921002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tiapride in 12 Huntington's disease patients.
    Quinn N; Marsden CD
    J Neurol Neurosurg Psychiatry; 1985 Mar; 48(3):292. PubMed ID: 3156967
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of psychiatric emergencies with a new neuroleptic drug: sultopride].
    Planche R
    Sem Hop Ther; 1976 Apr; 52(4):261-2. PubMed ID: 948771
    [No Abstract]   [Full Text] [Related]  

  • 34. New perspectives in psychiatric research. Proceedings of the WPA regional symposium organized by the Finnish Psychiatric Association in Helsinki, Finland, June 18-21, 1984.
    Acta Psychiatr Scand Suppl; 1985; 319():1-180. PubMed ID: 3863454
    [No Abstract]   [Full Text] [Related]  

  • 35. Amisulpride: its role in the therapeutic management of the schizophrenic patient. Introduction.
    Darcourt G
    Acta Psychiatr Scand Suppl; 2000; 400():5-6. PubMed ID: 10823304
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sulpiride: an atypical neuroleptic with a wide spectrum of therapeutic claims].
    Wasieczko A; Wasieczko Z
    Psychiatr Pol; 1996; 30(6):1009-16. PubMed ID: 9132763
    [No Abstract]   [Full Text] [Related]  

  • 37. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor agreement amongst psychiatrists assessing rationality in five cases of psychiatric polypharmacy.
    Lochmann van Bennekom MW; Gijsman HJ; de Beurs E; Zitman FG
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1069-71. PubMed ID: 18343550
    [No Abstract]   [Full Text] [Related]  

  • 39. A single-blind comparison of bromperidol and sulpiride in hospitalized schizophrenics.
    Yamagami S; Hirayama E; Mui K; Okuno M; Kioka T; Soma T; Ohno K
    Acta Psychiatr Belg; 1993; 93(4):236-44. PubMed ID: 7913572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amisulpride: its role in the therapeutic management of the schizophrenia patient. Conclusions.
    Peuskens J
    Acta Psychiatr Scand Suppl; 2000; 400():28-9. PubMed ID: 10823309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.